Loading
Latest filing published 24 Jul 2026 for 삼진제약. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of 전상진 in 삼진제약. Between 26 April 2021 and 24 July 2026, the trades on record add up to 36 filings.
The open-market record is one-sided, with 35 purchases and not one sale. The amount is not disclosed for 35 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The 34 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 24 July 2026: a transaction, in 삼진제약. The most recent open-market purchase was published on 16 October 2024, 732 days ago. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations